enGene Holdings Inc.

ENGN Stock Healthcare Biotechnology
$1.82
-0.08 (-4.45%)
Price as of Aug 28, 2026 market close

Performance

1 Month
+3.7%
3 Months
-1.4%
YTD
-79.8%
1 Year
-57.9%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
122.2%
Largest decline max drawdown, since Aug 2025
-88.2%
Risk-adjusted return Sharpe ratio, 1-year
0.29

Own ENGN?

See how ENGN contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.